Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States
Date
2021-03Permanent link
https://hdl.handle.net/11351/12493DOI
10.1016/j.jcyt.2020.11.008
ISSN
1477-2566
WOS
000620706900010
PMID
33483292
Keywords
Drug approval; Genetic therapy; JurisprudenceBibliographic citation
Iglesias-Lopez C, Obach M, Vallano A, Agustí A. Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States. Cytotherapy. 2021 Mar;23(3):261–74.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4476]
The following license files are associated with this item:





